Category: Healthcare

The global stereotactic radiation therapy (SRT) market is projected to reach USD 8.9 billion by 2035, expanding at a CAGR of 8.3% between 2025 and 2035.

The global stereotactic surgery devices market is projected to grow from USD 27.34 billion in 2024 to USD 40.36 billion by 2034, achieving a 5.1% CAGR during the forecast period.

The Prurigo Nodularis Treatment Market is witnessing notable growth due to increasing awareness of rare diseases, advancements in dermatological treatments, and the growing prevalence of skin conditions. The market size, which stood at USD 694.3 million in 2025, is anticipated to reach USD 931.9 million by 2035, reflecting a CAGR of 4.0%.

The global pulse oximeter market is projected to reach USD 3.5 billion by 2025, expanding at a CAGR of 8.6% over the forecast period. By 2035, the market is anticipated to surpass USD 6.1 billion, driven by the rising prevalence of respiratory diseases, increasing awareness of oxygen monitoring, and advancements in medical device technology.

The global sterile injectable contract development and manufacturing organization (CDMO) market is projected to expand significantly, growing from US$ 12.1 billion in 2024 to US$ 34.7 billion by 2034, at a compound annual growth rate (CAGR) of 12.7%.

The global steroid-free nasal sprays market is expected to reach US$ 16.91 billion by 2035, up from US$ 9.58 billion in 2025. The market is forecasted to grow at a CAGR of 7.4% during the forecast period

The global stethoscope hygiene devices market is projected to reach US$ 92.4 million by 2035, up from US$ 48.4 million in 2025, growing at a CAGR of 7.9% over the forecast period.

The global sterilants market is projected to experience robust growth, reaching US$ 5.24 billion by 2035, up from US$ 3.36 billion in 2025. The market is expected to expand at a CAGR of 7% during the forecast period

The global sterile dosage form market is projected to expand significantly, reaching USD 1.2 billion by 2035, with a CAGR of 7.7% from 2025 to 2035. This market, valued at USD 583.9 million in 2025, is experiencing substantial growth due to the rising demand for injectable medications, biologics, and ophthalmic solutions, alongside advancements in aseptic…

The Psoriasis Biosimilars Market is undergoing rapid expansion, fueled by the increasing prevalence of psoriasis and rising demand for cost-effective biologics. The market, valued at US$ 10,228.6 million in 2025, is projected to reach US$ 27,679.9 million by 2035, expanding at a CAGR of 12.2% over the forecast period.